Lung cancer begins in the lungs and has become the leading cause of cancer deaths in the United States for both men and women--claiming more lives than colon, ovarian, prostate, and breast cancer combined. There are two types of lung cancer: small and non-small based on the appearance of the cancer cells on the microscope. Non-small cell lung cancer accounts for approximately 85% of lung cancers and include squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Risk for being diagnosed with lung cancer includes smoking, second hand smoke, exposure to radon gas, asbestos, and other chemicals, excessive alcohol use, and a family history. Treatments depend on the stage as well as type of lung cancer but include: surgery, chemotherapy, radiation, targeted drug therapy, and clinical trials. There are four stages of non-small cell lung cancer that affects treatment plans.
Top Research Reagents
We have 141 products for the study of Stage, Nonsmall Cell Lung Cancer that can be applied to Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot from our catalog of antibodies and ELISA kits.
![Western Blot: CMAS Antibody (5A2) [H00055907-M01] - CMAS monoclonal antibody (M01), clone 5A2. Analysis of CMAS expression in Raw 264.7.](https://images.novusbio.com/fullsize/CMAS-Antibody-5A2-Western-Blot-H00055907-M01-img0015.jpg)
![Immunocytochemistry/Immunofluorescence: CMAS Antibody (5A2) [H00055907-M01] - Analysis of monoclonal antibody to CMAS on HeLa cell. Antibody concentration 10 ug/ml.](https://images.novusbio.com/fullsize/CMAS-Antibody-5A2-Immunocytochemistry-Immunofluorescence-H00055907-M01-img0009.jpg)
